von Hippel-Lindau disease: genetic and clinical observations.
Iliopoulos
O
O
MGH Cancer Center, Harvard Medical School, Boston, Mass., USA. iliopoul@helix.mgh.harvard.edu
D000310:Adrenal Gland Neoplasms / Q000209:etiology; D001932:Brain Neoplasms / Q000209:etiology; D016147:Genes, Tumor Suppressor; D018325:Hemangioblastoma / Q000209:etiology; D006801:Humans; D007680:Kidney Neoplasms / Q000209:etiology; D008025:Ligases / Q000235:genetics* / Q000502:physiology; D009154:Mutation; D010453:Peptide Synthases / Q000378:metabolism; D010673:Pheochromocytoma / Q000209:etiology; D044843:SKP Cullin F-Box Protein Ligases; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D006623:von Hippel-Lindau Disease / Q000150:complications / Q000235:genetics* / Q000628:therapy
D025521:Tumor Suppressor Proteins; D044843:SKP Cullin F-Box Protein Ligases; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D008025:Ligases; D010453:Peptide Synthases; C497446:VHL protein, human